Administration time difference of candesartin effect on albuminuria in type 2 diabetic patients.
Shimizu
Hiroyuki
H
Uehara
Yutaka
Y
Ohsaki
Aya
A
Okada
Shuichi
S
Mori
Masatomo
M
D000328:Adult; D000368:Aged; D000419:Albuminuria / Q000517:prevention & control*; D047228:Angiotensin II Type 1 Receptor Blockers / Q000008:administration & dosage / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000008:administration & dosage* / Q000627:therapeutic use*; D001713:Biphenyl Compounds; D001786:Blood Glucose / Q000378:metabolism; D001794:Blood Pressure / Q000187:drug effects; D003924:Diabetes Mellitus, Type 2 / Q000652:urine*; D003928:Diabetic Nephropathies / Q000517:prevention & control / Q000652:urine; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D013777:Tetrazoles / Q000008:administration & dosage* / Q000627:therapeutic use*; D013997:Time Factors; D055815:Young Adult
D047228:Angiotensin II Type 1 Receptor Blockers; D001562:Benzimidazoles; D001713:Biphenyl Compounds; D001786:Blood Glucose; D013777:Tetrazoles; C081643:candesartan